May 03, 2022
China’s Over-the-Counter (OTC) drug market, valued $19 billion, with 6% annual growth rate is expected to reach $26 billion by 2026. It accounts for one third of the total Asia-Pacific OTC market and keeps growing driven by the rising income of China’s huge population and the increasing trend in self-managed care.
Popular OTC drugs in China include traditional Chinese medicines, cough and cold medicines, vitamins and minerals, indigestion medicines, analgesics, medicated skincare products, topical medicines, band-aid and other first aid supplies, and similar products.
The National Medical Products Administration’s (NMPA) new drug registration regulation has streamlined the OTC drug registration procedures and process. It has shortened the time to bring OTC drugs to the market and enhanced market opportunities for U.S. OTC drugs, which are well-regarded by Chinese consumers for their safety, quality, and efficacy.
This webinar will provide an overview of China’s OTC drug market, market opportunities, market access requirements, IP considerations, and best practices. We will also introduce cross-border e-Commerce channels for selling OTC drugs.
Make sure your questions get answered ahead of time! Please email kerry.barnett@trade.gov with topics you would like discussed or questions you would like answered during the webinar.
For more information please contact: Kerry.Barnett@trade.gov
